Advanced Intravascular MRI for Assessing Atherosclerosis

用于评估动脉粥样硬化的先进血管内 MRI

• 批准号: 7658833
• 负责人: PAUL A BOTTOMLEY
• 金额: $ 41万
• 依托单位: JOHNS HOPKINS UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-08-01 至 2012-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7658833
• 关键词: Adoption; Adverse effects; Aorta; Area; Arterial Fatty Streak; Arteries; Atherosclerosis; Biocompatible; Blood Vessels; Caliber; Catheterization; Catheters; Clinic; Clinical; Clinical Research; Contrast Media; Coronary artery; Data; Data Analyses; Deposition; Detection; Development; Device Safety; Devices; Diagnosis; Diagnostic radiologic examination; Electromagnetic Fields; Endoscopes; Endoscopy; Exhibits; Eye; Feedback; Fluoroscopy; Frequencies; Future; Hand; Heating; Histology; Human; Image; In Vitro; Injury; Ionizing radiation; Laboratories; Lesion; Location; Magnetic Resonance Imaging; Measures; Methods; Modeling; Morbidity - disease rate; Morphology; National Heart, Lung, and Blood Institute; Noise; Operative Surgical Procedures; Oryctolagus cuniculus; Pathology; Patients; Performance; Phase; Physiologic pulse; Positioning Attribute; Process Assessment; Radio; Radio-Opaque; Reading; Research; Resolution; Roentgen Rays; Rupture; Safety; Sampling; Severities; Severity of illness; Signal Transduction; Site; Slice; Speed; Stenosis; Surface; System; Temperature; Testing; Thermometry; Time; Ultrasonography; Work; arterial lesion; base; calcification; design; design and construction; detector; electrical property; experience; image guided intervention; imaging detector; improved; in vitro testing; in vivo; mortality; new technology; prototype

DESCRIPTION (provided by applicant): Atherosclerosis and its complications are leading causes of morbidity and mortality. The presence and severity of disease is typically diagnosed by luminal narrowing at X-ray catheterization. Because X-ray imaging does not visualize vessel walls, it does not allow assessment of processes that precede advanced plaque formation, or the vulnerability of plaques to rupture. Other current imaging approaches have difficulty distinguishing plaque components and with spatial and temporal resolution. Such issues are identified by NHLBI as central problems for image-guided intervention. Intravascular magnetic resonance imaging (IVMRI) promises precise, high-contrast assessment of stenoses and vessel wall pathology without ionizing radiation. Previously, ~1 mm diameter biocompatible intravascular guidewires were developed as active MRI detectors for clinical 1.5 Tesla (T) scanners in our laboratories, but have not gained wide use. Maximizing speed, sensitivity and spatial resolution are key to clinical use. While whole-body 3T MRI has emerged as a new clinical research standard, delivering higher signal-to-noise ratio (SNR) than existing 1.5T scanners, IVMRI detectors are limited to 1.5T, and thus have not benefited from any 3T SNR gain. One problem is a 4-fold increase in potential heating of introduced metallic devices at 3T vs 1.5T, all else being constant. We present new preliminary experimental and theoretical data demonstrating an over 3-fold gain in SNR and over 10-fold increase in the area of sensitivity or field-of-view (area exhibiting the same SNR) for equivalent intravascular antennae at 3T vs 1.5T. We show that heating can be kept within safe levels during 3T MRI. Such performance gains offer huge potential for high-contrast, high-resolution IVMRI for the in vivo assessment of atherosclerosis. Aim 1 develops and tests active, biocompatible high-SNR, high-FOV intravascular guidewires for 3T MRI. Image-guided device tracking requires high-speed MRI. However, conventional MRI is locked to the scanner's frame-of-reference (FoR), requiring time-consuming "read-out" of device location to prescribe MRI gradients for new locations. Aim 2 develops a new MRI approach that uses the antenna itself for excitation, intrinsically locking the image FoR to the active end of the probe. The antenna becomes an "MR-eye", generating images of what it "sees" as it courses through an artery like an endoscope. Because the MRI-excited volume is vastly reduced to the vicinity of the probe, heating potential is greatly reduced. Aim 3 tests these new technologies in an in vivo rabbit atherosclerosis model, where the aorta is of comparable diameter to human coronary arteries. These developments will form a basis for future human use.

描述（由申请人提供）：动脉粥样硬化及其并发症是发病率和死亡率的主要原因。疾病的存在和严重程度通常通过x线导管检查时的管腔狭窄来诊断。由于x射线成像不能看到血管壁，因此不能评估斑块形成之前的过程，也不能评估斑块破裂的易损性。其他目前的成像方法难以区分斑块成分和空间和时间分辨率。NHLBI将这些问题确定为图像引导干预的核心问题。血管内磁共振成像（IVMRI）有望在没有电离辐射的情况下精确、高对比度地评估血管狭窄和血管壁病理。以前，在我们的实验室中，~ 1mm直径的生物相容性血管内导丝被开发为临床1.5特斯拉(T)扫描仪的主动MRI探测器，但尚未得到广泛应用。最大限度地提高速度、灵敏度和空间分辨率是临床应用的关键。虽然全身3T MRI已成为一种新的临床研究标准，提供比现有1.5T扫描仪更高的信噪比（SNR），但IVMRI检测器仅限于1.5T，因此无法从任何3T信噪比增益中受益。其中一个问题是，在其他条件不变的情况下，引入的金属器件在3T和1.5T时的潜在加热增加了4倍。我们提出了新的初步实验和理论数据，表明等效血管内天线在3T和1.5T下的信噪比增益超过3倍，灵敏度或视场面积（显示相同信噪比的区域）增加超过10倍。我们表明，在3T MRI期间，加热可以保持在安全水平。这种性能的提高为高对比度、高分辨率的IVMRI在体内评估动脉粥样硬化提供了巨大的潜力。Aim 1开发并测试了用于3T MRI的活性、生物相容性高信噪比、高视场的血管内导丝。图像引导设备跟踪需要高速MRI。然而，传统的MRI被锁定在扫描仪的参考框架（FoR）上，需要耗时的“读出”设备位置来规定新位置的MRI梯度。Aim 2开发了一种新的MRI方法，该方法使用天线本身进行激励，本质上将图像锁定在探头的主动端。天线变成了一个“磁共振眼”，当它像内窥镜一样穿过动脉时，会产生它“看到”的图像。由于mri激发体积在探针附近大大减小，热势大大降低。目的3在兔体内动脉粥样硬化模型中测试这些新技术，其中主动脉直径与人类冠状动脉相当。这些发展将为未来人类的使用奠定基础。